ストックスクリーナーアプリを入手
9.315
3.57%
-0.345
前日終値:
$9.66
開ける：
$9.74
24時間の取引高:
252.24K
Relative Volume:
1.30
時価総額：
$453.02M
収益：
$62.02M
当期純損益:
$-45.65M
株価収益率:
-10.12
EPS:
-0.92
ネットキャッシュフロー:
$-9.60M
1週間 パフォーマンス:
-3.07%
1か月 パフォーマンス:
+1.80%
6か月 パフォーマンス:
+15.86%
1年 パフォーマンス:
+6.34%
1日の値動き範囲:
$9.27
$9.74
1週間の範囲:
$9.27
$10.05
52週間の値動き範囲:
$7.44
$10.90
Theravance Biopharma Inc Stock (TBPH) Company Profile
名前
Theravance Biopharma Inc
セクター
電話
650-808-6000
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
9.315 | 453.02M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 開始されました | BTIG Research | Buy |
| 2024-01-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2021-11-05 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-15 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2021-08-25 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 開始されました | JP Morgan | Overweight |
| 2020-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 開始されました | Cowen | Outperform |
| 2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-06 | アップグレード | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-29 | 再開されました | Piper Jaffray | Overweight |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-06-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-12-21 | 開始されました | Needham | Buy |
| 2016-11-03 | 開始されました | Piper Jaffray | Overweight |
| 2016-10-12 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 開始されました | Guggenheim | Buy |
| 2016-06-20 | 繰り返されました | Leerink Partners | Outperform |
| 2016-05-12 | 開始されました | Leerink Partners | Outperform |
| 2016-05-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | アップグレード | Robert W. Baird | Underperform → Neutral |
すべてを表示
Theravance Biopharma Inc (TBPH) 最新ニュース
Theravance Biopharma (TBPH) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Inside Access: Theravance Biopharma's Strategic Update at Elite Healthcare Conference - StockTitan
(TBPH) Technical Data - Stock Traders Daily
Theravance biopharma SVP Rhonda Farnum sells $36,000 in shares - MSN
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation - Yahoo Finance
Theravance Biopharma Earnings: Key Financial Results Coming February 26What's Next for TBPH? - StockTitan
TBPHTheravance Biopharma, Inc. Latest Stock News & Market Updates - StockTitan
Theravance Biopharma to Participate in an Upcoming Investor Conference - PR Newswire
Exclusive: Theravance Biopharma Takes Center Stage at Major Healthcare Conference - StockTitan
Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock? - MSN
Theravance Biopharma (NASDAQ:TBPH) Hits New 12-Month High – Should You Buy? - Defense World
Theravance Biopharma (NASDAQ:TBPH) Trading Up 8.8%Still a Buy? - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Reaches New 12-Month HighHere's Why - MarketBeat
Theravance Biopharma stock hits 52-week high at $10.47 - MSN
Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Rhonda Farnum Sells 4,000 Shares - MarketBeat
Theravance Biopharma stock hits 52-week high at $10.47 By Investing.com - Investing.com South Africa
Theravance Biopharma (NASDAQ:TBPH) shareholders are up 15% this past week, but still in the red over the last five years - Simply Wall St
Theravance biopharma SVP Rhonda Farnum sells $36,000 in shares By Investing.com - Investing.com UK
JPMorgan Chase & Co. Acquires 7,620 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Barclays PLC Increases Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Barclays PLC Has $529,000 Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
How To Trade (TBPH) - Stock Traders Daily
Zacks Research Issues Optimistic Estimate for TBPH Earnings - Defense World
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Research Report 2024-2030 Featuring Allergan, Basilea Pharmaceutica, Merck, Pfizer, The Medicines Co, Theravance Biopharma - GlobeNewswire
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - GlobeNewswire
(TBPH) On The My Stocks Page - Stock Traders Daily
Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH) - Yahoo Finance
Franklin Resources Inc. Trims Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Barclays PLC Has $529,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Jane Street Group LLC Raises Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Sold by State Street Corp - MarketBeat
State Street Corp Decreases Stock Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 21,372 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Wellington Management Group LLP Sells 159,258 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
When (TBPH) Moves Investors should Listen - Stock Traders Daily
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference - PR Newswire
Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue? - MSN
The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable - Yahoo Finance
Diabetic Gastroparesis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Theravance Biopharma, Eli Lilly and Company, Processa Pharmaceuticals, PTC Therapeutics - The Globe and Mail
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
What is Zacks Research's Estimate for TBPH FY2024 Earnings? - MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Acquired by BNP Paribas Financial Markets - MarketBeat
(TBPH) Trading Advice - Stock Traders Daily
Theravance Biopharma Inc (TBPH) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):